학술논문
ABCL-181: Updated Results of a Phase 2 Study from GELTAMO Investigating the Combination of Ibrutinib with R-GEMOX in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma.
Document Type
Academic Journal
Author
Source
Subject
Language
English
ISSN
2152-2650